Dr Paulo Rocha is developing a low-cost integrative sensing tool for early...
Dr Paulo Rocha is developing a low-cost integrative sensing tool for early detection of Dengue virus, using a novel platform containing electrical sensors to investigate the behaviour of human cells infected with Dengue virus.
Source: University of Bath

Sensing tool could detect Dengue fever earlier

Researchers from the University of Bath are developing a new tool for detecting the presence of Dengue fever early on, helping prevent people from suffering potential life-threatening complications.

Dr Paulo Rocha from the University of Bath’s Department of Electronic & Electrical Engineering is developing a low-cost integrative sensing tool for early detection of Dengue virus, using a novel platform containing electrical sensors to investigate the behaviour of human cells infected with Dengue virus.

When someone is infected by the Dengue virus it produces proteins, particularly ‘non-structural protein 1’ (NS1) which is secreted from infected cells. Using a three centimetre squared platform, the Bath-based research team will observe the electrical behaviour of human cells in vitro infected by different concentrations of NS1. A better understanding of the electrical behaviour of these cells, the researchers believe, will help create a more accurate and sensitive way of detecting the presence of Dengue virus.

In the future, it is hoped this research will lead to the development of a low cost, disposable, real time wearable system for detecting Dengue fever as well as Zika virus and Yellow Fever virus, both of which belong to the same Flaviviridae family. This will be of particular benefit to communities in developing countries where access to healthcare may be limited and Dengue fever is particularly prevalent.

Dengue fever is an incurable mosquito-borne tropical disease initiated by the Dengue virus. It is spread by mosquitos mostly in tropical and subtropical areas of the world with symptoms ranging from fever and muscle/joint pains to life threatening Dengue hemorrhagic fever. Each year it is estimated 390 million dengue infections occur around the world. Of these, 500,000 cases develop into dengue haemorrhagic fever which results in up to 25,000 deaths annually worldwide.

A method that doctors currently adopt to test for Dengue fever is by examining the presence of NS1 in a patient’s bloodstream through a simple blood test. However, many people who are infected by Dengue virus may not be diagnosed due to the concentration of NS1 being so low and therefore not detected. This prevents correct diagnosis and the early intervention of drugs to counteract and reduce the effects of the virus.

“If we can detect Dengue fever earlier on, we can ultimately efficiently treat a person’s symptoms and prevent the virus from developing into a more serious infection. By determining if there is a correlation with a cell’s electrical signal and the presence – no matter how little the concentration – of NS1, we can identify if someone is infected with Dengue virus earlier,” said Rocha.

Subscribe to our newsletter

Related articles

A pill-sized heating device for diagnostic testing

A pill-sized heating device for diagnostic testing

Researchers have developed a ‘heater’ — about the size of a pill tablet — that regulates the temperature of biological samples through the different stages of diagnostic testing.

A novel swab design to augment COVID-19 testing

A novel swab design to augment COVID-19 testing

Scientists have developed a novel test swab that can be 3D printed using inexpensive, widely available materials and speedily assembled in a range of fabrication settings.

"Access checker" remotely measures body temperature

"Access checker" remotely measures body temperature

An innovative measurement method is helping to detect people infected with coronavirus from a safe distance. It detects fever, increased pulse rates and fast breathing without endangering the person conducting the testing.

'Organ-on-a-chip' finds out how COVID-19 invades our bodies

'Organ-on-a-chip' finds out how COVID-19 invades our bodies

In order for a COVID-19 vaccine and antiviral drugs to be developed, scientists first need to understand why this virus spreads so easily and quickly, and why it invades our bodies with seemingly little resistance from our immune system.

A 3D-printed diffuser to treat COVID-19 patients

A 3D-printed diffuser to treat COVID-19 patients

Scientists have delivered more than 200 3D-printed diffusers for metered dose inhalers (MDI) to the Houston hospital and stands ready to produce more if needed.

A robotic COVID-19 testing lab

A robotic COVID-19 testing lab

Scientists are creating from scratch a diagnostic lab with the capability to process more than 1,000 patient samples per day.

AI, App provide at-home assessment of coronavirus risk

AI, App provide at-home assessment of coronavirus risk

A coronavirus app coupled with machine intelligence will soon enable an individual to get an at-home risk assessment based on how they feel and where they've been in about a minute.

Lensless microscopy chip for diagnostic applications

Lensless microscopy chip for diagnostic applications

Researchers at the University of Connecticut have developed a lensless microscope that allows an observer to enjoy an enormous field of view.

Biosensors detect for tumors and dengue fever

Biosensors detect for tumors and dengue fever

Researchers have developed a tumor biosensing chip that can help determine the optimum dosage of chemotherapy required for a cancer patient.

Popular articles